P - Poster Session
Kidney Posters

Monday July 02, 2018 | 16:30 to 17:30
Room: Hall 10 - Exhibition
Track: Kidney


Miss María Ovidia López-Oliva, Spain
Incidence of contrast-induced nephropathy in kidney transplant patients

Ms. Fernanda Salomao Gorayeb-Polacchini, Brazil
Delayed graft function in kidney transplant: A pair analysis

Mr. Julian Doricic, Germany
Systemic free heme increases the risk foracute kidney injury (AKI) after solid organ transplantation

Dr. Yuki Nakamura, Japan
Efficacy and safety of early mammalian target of rapamycin inhibitors with minimization of calcineurin inhibitors in kidney transplant recipients

Dr. Ksenija Vučur, Croatia
Prognostic significance of microvascular injury in kidney transplant recipients

Dr. Eriawan Agung Nugroho, Indonesia
The profile of kidney transplantation in Dr. Kariadi Hospital Semarang, Indonesia: A single centre experience

Dr. Asuncion Sancho Calabuig, Spain
Kidney transplantation in recipients older than 70 years old: A good option for our patients

Dr. Jeong-Hoon Lim, Korea
Distribution of anti-ABO immunoglobulin G subclass and C1q antibody in ABO incompatible kidney transplantation

Prof. In Sung Moon, Korea
The outcome of kidney transplant recipients who had combined ABO incompatibility and performed antibody against donor HLA antigen

Dr. Yuki Nakagawa, Japan
Is it really necessary to remove anti-A/B antibodies in ABO-incompatible kidney transplantation?

Dr. Yoji Hyodo, Japan
The new desensitization protocol for ABO incompatible living donor kidney transplantation using low dose rituximab without plasmapheresis

Prof. Raj Kumar Sharma, India
Effect of vitamin D deficiency on antibody-mediated rejection (ABMR): a comparative analysis of live-related ABO-incompatible and abo-compatible renal transplantation

Dr. Feroz Aziz, India
ABO-incompatible transplantation without conventional induction immunosuppression (IL-2RB or Depleting agents )

Dr. Georgina Irish, Australia
Screening for urinary chemokines in long term renal transplant patients associates with cellular rejection, microvascular damage and falls in GFR over time

Dr. Masayuki Tasaki, Japan
Bortezomib eliminates plasma cells from the renal graft in plasma cell-rich acute rejection

Miss Lucia C. Rodriguez Gayo, Spain
Acute rejection and short-term outcomes in highly sensitized kidney transplant recipients

Dr. Gervasio Soler Pujol Sr., Argentina
Immunologic and histologic monitoring after renal transplantation a single center experience

Dr. Esther González Monte Sr., Spain
Kidney transplantation from uncontrolled donation after circulatory death, our outcomes compared to donation after brain death after very long time.

Dr. Soo Jin Lim, Malaysia
Kidney Transplant in Highly Sensitized Patients: University Malaya Medical Centre’s Experience

Mrs. Patricia Ramirez, Spain
Functional outcomes of the renal transplants obtained from controlled donation following cardiopulmonary death (DCD) with compartmental normothermic extracorporeal membrane oxygenation support (NECMO)

Dr. Antonios Arvelakis, United States
Racial and socioeconomic influences on kidney transplantation outcomes, a 10 year retrospective study

Prof. Xiao-Peng Yuan, P.R. China
The effect of chronic lesions in implantation biopsy on the function and survival of renal grafts from donation after cardiac death donors

Dr. Daisuke Toki, Japan
Glomerular abnormalities associated with chronic calcineurin inhibitor nephrotoxicity in late renal allograft biopsies

Dr. Veronica Lopez, Spain
Kidney donor profile index: The impact on graft survival in deceased donor kidney transplant recipients

Dr. Feng Han, P.R. China
How to select the non-heartbeating donors suffering from CPR

Dr. Miyeun Han, Korea
The short term outcome of deceased donor kidney transplantation with a short cold ischemic time is comparable to that of living donor kidney transplantation

Dr. Susana M. Norton, Portugal
Kidney transplantation from circulatory death donors with abdominal normothermic oxygenated recirculation support: The impact of cold ischemia

Dr. Victoria Gomez Dos Santos, Spain
Perfusion parameters during hypothermic machine perfusion in expanded criteria donors (ECD) and donors after circulatory death (DCD) does comparison allow their categorization?

Dr. Kunal Kapoor, India
Deceased donor renal transplantation: A single tertiary care center experience

Miss Moira H. Bruintjes, Netherlands
Double J is superior to externally draining ureteric stent in enhancing recovery after living donor kidney transplantation

Prof. Feza Yarbug Karakayali, Turkey
Our experience with paired kidney exchange transplantation

Dr. Mahir Kirnap, Turkey
The new crescentic incision: A good option for donor nephrectomy

Ms. Abeera Ali, Canada
Taking specific steps to pursue living donor kidney transplant is associated with greater odds of receiving a living donor offer

Dr. Hajime Hirano, Japan
Expanding the donor pool: Experience of living kidney transplantation from very old aged donor in our center

Dr. Yu Kihara, Japan
Outcomes of living-donor kidney transplants for long-term dialysis patients

Dr. Rehan Mohsin, Pakistan
Right sided laparoscopic donor nephrectomy - dream comes true

Dr. Khalid Alqasim, Germany
Criteria and relevant prognostic factors in donor selection, an analysis of 266 consecutive donor nephrectomies

Prof. Youngkyoung You, Korea
Migration of the Dacron interposition graft for middle hepatic vein reconstruction in living donor liver transplantation

Mrs. Bernadette B.J.J.M. Haase-Kromwijk, Netherlands
Kidney exchange programs in Europe (COST-ENCKEP) what can we learn from each other?

Dr. Ann Bugeja, Canada
Overweight kidney donors gain weight after donation

Dr. Gulshanova F Sitorabonu, Tajikistan
The condition of the transplant service in the republic of Tajikistan

Dr. Engida Abebe Gelan, Ethiopia
Patient characteristics and outcomes following establishment of a living donor kidney transplant program in Sub-Saharan Africa

Prof. Sam Minh Thai, Viet Nam
Long-term follow-up after short renal vein repair procedure in kidney transplantation

Dr. Yingxin Fu, P.R. China
Relevance between living donors ‘renal reserve capacity and recipients graft function'-retrospective study of 72 cases of living donor kidney transplantation

Dr. Lee-Moay Lim, Taiwan
Whole-exome sequencing identified mutational profiles of de novo urothelial carcinoma after kidney transplantation

Sara Jiménez, Spain
Tumors in native kidney and renal grafts after renal transplantation. Experience of our centre

Mrs. Snježana Šulc, Croatia
Long-term cancer incidence in kidney transplant recipients in relation to the first posttransplant year immunossuppresion intensity

Mr. Jacek Zawierucha, Poland
Malignancy in a potential kidney allograft recipients-how important is the problem?

Dr. Nuria Montero, Spain
Effect of body weight variation in kidney transplantation: A retrospective cohorts study

Prof. Nihal Uslu, Turkey
Biopsy-related renal allograft arteriovenous fistulas: A series of 5 cases

Dr. Ming-Che Lee, Taiwan
Associations between high serum adipocyte fatty acid binding protein and first hospitalization in kidney transplantation patients

Dr. Burak Sayin, Turkey
Spot urinary sodium may be an indicator for high blood pressure and metabolic syndrome in kidney transplant recipients

Dr. Joanna Pazik, Poland
Malnutrition in kidney allograft recipients treated with mycophenolate mofetil is associated with IMPDH1 rs2278294 polymorphism.

Dr. Jose Luis Santiago, Spain
Genetic associations of polymorphism located at loci relevant for kidney function in a cohort of kidney transplant recipients

Dr. Indira Ramilyeva, Kazakhstan
Features of distribution of HLA antigens in patients with chronic kidney disease in Kazakhstan

Dr. Pilar Auñón, Spain
Chronic hypotension in dialysis is a prognostic factor in the evolution of kidney transplantation

Dr. Marta Sękowska, Poland
Can we use donor and recipient neutrophil gelatinase-associated lipocalin (NGAL) to predict graft function

Prof. Sangmok Yeo, Korea
Long term outcomes of kidney transplantation with primary glomerulonephritis

Miss Tamar A.J. van den Berg, Netherlands
Blind spots in evidence-based medicine: The lack of knowledge on imaging and kidney transplantation

Dr. Lara Belmar Vega, Spain
Relationship between the histological findings obtained by 1-year protocol biopsies and kidney transplant failure score (KTFS)

Mrs. Victoria E. García, Spain
Influence of pre-kidney transplant secondary hyperparathyroidism on later evolution after renal transplantation

Dr. Emil Holmström, Finland
The impact of deceased donor simvastatin treatment on kidney transplant outcomes - Results of a double-blinded, randomized controlled trial

Miss Monika Ashwin, Canada
Examining shared-care models for the long-term management of stable kidney transplant recipients

Prof. Jongwon Ha, Korea
The potential role of Klotho as a prognostic biomarker in deceased donor kidney transplantation

Randall Lou-Meda, Guatemala
Results of a pediatric transplant program in a low income country: 10 years of Guatemalan experience

Dr. Vladimir Tennak, Israel
Single anastomosis of double ureter kidneys – Experience in 12 kidney transplant recipients

Miss Harkiran Sran, United Kingdom
Safety and efficacy of robot-assisted kidney transplantation

Dr. Takeshi Ishimura, Japan
Voiding function of kidney transplanted recipients with bladder capacity abnormality in congenital renal hypoplasia/dysplasia

Dr. Dorian H. Toledo, Guatemala
Morphological and functional changes of the heart six months after renal transplantation

Dr. Javier Juega, Spain
Technical characteristics, optimization and outcomes of ultrasound guided biopsy performed on kidney transplant patients

Dr. Mariana A Seija II, Uruguay
Non-immunological factors in chronic kidney disease in kidney transplant

Dr. kei kurihara, Japan
Utility of contrast-enhanced ultrasonography for a diagnosis of rejection after kidney transplantation

Ms. Maya Deeb, Canada
Early post-operative acute myocardial infarction in kidney transplant recipients: Incidence, risk factors, and outcomes

Dr. Ivana Dedinska, Slovakia (Slovak Republic)
Leptin – new marker for rejection of kidney transplant?

Dr. Lampros Kousoulas, Germany
Clinical characteristics and outcomes of renal transplant recipients after abdominal surgical procedures not connected with transplantation

Mr. Javier De Teresa Alguacil, Spain
Life after kidney transplant in 600 recipients in southern Spain

Mrs. Ester Casillas Sagrado, Spain
Progression of renal function after treatment with the new antivirals for hepatitis C: Is there a difference between chronic kidney disease and kidney transplant patients?

Mrs. Jolanta Gozdowska, Poland
Urine levels of CCL2 and CXCL10 as potential biomarkers of kidney allograft function: A pilot study

Dr. Gabriel E Chanta, Argentina
Resistive index of renal grafts: Its relation to systemic and renal vascular factors

Dr. Masaaki Yanishi, Japan
Related factors of osteosarcopenia in kidney transplant recipients

Dr. Christos Nikolaidis, Greece
Renal Paratransplant Hernia. An Uncommon Variant of Internal Hernia. A Review of the Literature

Fabienne Dobbels, Belgium
Establishing a core outcome measure for life participation: A standardized outcomes in nephrology – kidney transplantation (SONG-Tx)consensus workshop report

Dr. Elif Kupeli, Turkey
The role of smoking on early postoperative pulmonary complications in renal transplantation patients

Dr. Serena Gatius, Spain
Causes and consequences of poliomavirus BK infection in kidney transplant recipients

Dr. Tomas Reischig, Czech Republic
Impact of viral load in polyoma-BK virus viremia on histologic findings in late protocol biopsy in kidney transplant recipients

Mr. Wenhua Lei, P.R. China
The Enhanced Recovery after Surgery for Patients Undergoing Kidney Transplantation Surgery

Miss Harkiran Sran, United Kingdom
Association between donor/recipient BK viral serostatus and risk of BK viraemia post-transplantation

Prof. Gokhan Moray, Turkey
Application of ileobladder for clinical kidney transplantation: Two case reports

Dr. Bryan Christian Gaza Ilagan, Philippines
Panel reactive antibody positivity and associated human leukocyte antigen antibodies in Filipino kidney transplant candidates at the national kidney and transplant institute

Dr. Antonia Alvarez Marquez, Spain
Analysis of kidney transplantation results of very highly sensitized patients included in a virtual crossmatch programme and their kidney pairs. Results of 5 years since the beginning of the protocol. Andalusian group for highly sensitized patients

Dr. Carlos Arias-Cabrales, Spain
Kdpi score: A comparison with classical ECD/SCD classification in predicting outcomes

Dr. Myung Hyun Lee, Korea
Kidney transplantation alone in end-stage renal disease patients with hepatitis B liver cirrhosis

Dr. Matthew P. Sypek, Australia
Factors associated with time to deceased donor renal transplant waitlisting or living donor transplantation in Australia

Prof. Puxun Tian, P.R. China
Clinical observation of single kidney transplantation for adult recipients from non-heartbeating pediatric donors

Dr. Marta L Monteverde, Argentina
Long-term outcome of focal segmental glomerulosclerosis after renal transplantation: A single-center experience

Prof. Taieb Ben Abdallah, Tunisia
IgA Nephropathy with Crescent Formation after Renal Transplantation

Dr. Ken Sakai, Japan
Significant survival improvement in recipients with lupus nephritis on kidney transplantation: Single center experience

Dr. Xiaobing Ju, P.R. China
Impact of single nucleotide polymorphisms on P450 oxidoreductase and peroxisome proliferator-activated receptor alpha on tacrolimus pharmacokinetics in renal transplant recipients

Dr. Iwai Tomoaki, Japan
Conversion from cyclosporine to once-daily tacrolimus at late post-transplant stage

Dr. Maria Luisa Rodríguez-Ferrero, Spain
Clinical experience of conversion from antimetabolites with standard exposure tacrolimus to everolimus with tacrolimus minimization in stable kidney transplanted recipients

Dr. Maria Luisa Rodríguez-Ferrero, Spain
Donor specific antibodies after conversion from mycophenolate mofetil with standard exposure tacrolimus to everolimus with tacrolimus minimization in stable kidney transplanted recipients

Dr. Kamilla Linhares-Silva, Brazil
Single reduced dose thymoglobuline as induction in kidney retransplant

Dr. Sonia Mehrotra, India
Pharmaco-dynamics of CSA and tacrolimus and its effect on antiviral drugs in HCV positive kidney transplant recipients

Dr. Junji Uchida, Japan
Late conversion to everolimus with calcineurin inhibitor minimization in stable kidney transplant recipients - analysis of factors affecting ΔeGFR

Dr. Fatima AlKendi, United Arab Emirates
Exceptional high dose tacrolimus requirement in a twin pregnancy post kidney transplant: Review and case report

Dr. Dheepa Ramasamy, Malaysia
Switching from Prograf® to Advagraf® in stable kidney transplant recipients- Do Asians differ?

Dr. Nuria Lloberas Blanch, Spain
Extended release tacrolimus (LCP-TAC) prolongs calcineurin activity inhibition during drug doses intervals

Luis Gaite, Argentina
Use of ATG FR in mode of single dose in recipients of renal transplantation. Experience of 2 transplant units of Sante Fe, Argentina

Luis Gaite, Argentina
Advagraf de novo. Use comparative of advagraf compared with prograf

© 2023 TTS2018